Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Vulvar Lichen Sclerosus: early-phase trial registry

1 of 2 indexed Vulvar Lichen Sclerosus trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Vulvar Lichen Sclerosus: 2 US clinical trials tracked, 1 recruiting.

Vulvar Lichen Sclerosus is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Jennifer R. Arthurs, running 1 of these trials.

Enrollment posture brief

Registry condition vulvar-lichen-sclerosus

OPEN 1 | RECR 50% | LATE 0 | EARLY 2 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Vulvar Lichen Sclerosus (thi…50%
Open-enrollment share among volume-matched conditions near Vulvar Lichen Sclerosus

Vulvar Lichen Sclerosus lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Vulvar Lichen Sclerosus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Vulvar Lichen Sclerosus is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 12

Phase Distribution

PhaseTrial count
Phase 1 2

Top Sponsors

Named interventions

Most-linked intervention names on Vulvar Lichen Sclerosus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Autologous Platelet-Rich Plasma (PRP) Biological
1 trials
Sham Procedure Other
1 trials
StrataMGT Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Vulvar Lichen Sclerosus trials. A trial with sites in several states counts in each.

Florida 2 trials
New York 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Vulvar Lichen Sclerosus page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Vulvar Lichen Sclerosus trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Jennifer R. Arthurs sponsors the most Vulvar Lichen Sclerosus trials on record, review their full trial history before evaluating a specific study. See Jennifer R. Arthurs's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Vulvar Lichen Sclerosus condition card totals 2 registered trials; most-linked intervention Autologous Platelet-Rich Plasma (PRP); top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.